Delivery Order SPE2DR25D7005-SPE2DR26F3EHR
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100 count) with a contract value of $3,574.21. This competitively awarded, non-set-aside delivery order was issued on September 30, 2025, with an ultimate completion date of October 1, 2025, and reflects a firm fixed-price arrangement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count bottles) with a ceiling value of $1,564.30. This firm fixed-price delivery order, which is set to be completed by September 16, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a non-set-aside competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units) with a ceiling value of $1,877.16. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 30, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100, with a ceiling value of $1,019.21. This is a firm fixed price, non-set-aside delivery order that will be completed by August 28, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100 count) with a ceiling value of $2,834.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,822.55. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100 units, with a ceiling value of $1,403.89. This contract utilizes a firm fixed price model with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100 units per package. This competitive delivery order, valued at $3,519.85 with firm fixed pricing, is scheduled for completion by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3EHRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packages) with a ceiling value of $2,107.09. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for this delivery order. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing prime vendor agreement with the Defense Logistics Agency's Medical Supply Chain. The contract reflects the company's ongoing role in supplying critical medications to military and federal healthcare systems. Ciprofloxacin is a widely-used fluoroquinolone antibiotic essential for treating bacterial infections across military medical facilities. The competitively awarded delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical requirements and support the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/1/25 |